Journal
STEM CELL RESEARCH
Volume 55, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.scr.2021.102475
Keywords
-
Ask authors/readers for more resources
In this study, PBMCs were collected from a patient with Fabry disease caused by a novel GLA gene mutation. An iPSC line was derived using an episomal reprogramming method, confirming the expected mutation and pluripotency status through various validation methods.
PBMCs were collected from a patient with a novel GLA gene mutation (c.140G > A) which contributed to Fabry disease. Subsequently, an induced pluripotent stem cell (iPSC) line was derived using an episomal reprogramming method that transfer the reprogramming plasmids expressing OCT3/4, SOX2, KLF4, LIN28 and L-MYC into the PBMCs. The expected mutation in the iPSC line was confirmed by Sanger sequencing, while the pluripotency status was validated by immunofluorescence assay and flow cytometry for pluripotency markers, as well as teratoma formation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available